openPR Logo
Press release

Hepatitis E Diagnostic Tests Market Rugged Expansion Foreseen by 2024

02-14-2018 11:31 AM CET | Health & Medicine

Press release from: TMR Research

Hepatitis E Diagnostic Tests Market Rugged Expansion Foreseen

Global Hepatitis E Diagnostic Tests Market: Overview

The global market for hepatitis E diagnostic tests is treading a growth path as the prevalence of hepatitis E, especially in resource-poor regions is on the rise. Hepatitis E which is caused due to hepatitis E virus is a chief cause of mortality and morbidity in the developing world. Lack of proper sanitation and frequent instances of water contamination in these countries are leading causes of infections and diseases such as hepatitis E. This has stoked demand for diagnostic tests for hepatitis E, especially among individuals between 15 and 40 years.

The hepatitis E diagnostic tests market is appropriately segmented based on test type, end user, and geography.

The report on the hepatitis E diagnostic tests market compiled by seasoned analysts examines every possible aspect that could influence the growth of this market over the forecast timeframe. The various segments under different categories have been studied and the profitability of key ones presented over the remaining.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=S&rep_id=3077

Global Hepatitis E Diagnostic Tests Market: Trends and Opportunities

The rising prevalence of hepatitis E across the world is the leading factor behind the growth of the hepatitis E diagnostic tests market. According to statistics of the WHO, almost 20 million people suffer from HEV infections each year, worldwide, of which nearly 3.3 million are symptomatic cases.

Some primary hepatitis E diagnostic tests are ELISA HEV IgM, RT-PCR, and ELISA HEV IgG. Of them, ELISA HEV IgM test kits account for the maximum demand due to the soaring incidence of hepatitis E worldwide; the demand for ELISA HEV IgM test kits is predicted to remain significantly high over the forecast period. The demand for RT-PCR test kits is likely to closely trail that of ELISA HEV IgM test kits in the upcoming years. The demand for RT-PCR is mainly because it delivers fast results and high sensitivities and specificities of molecular assay. The segment of ELISA HEV IgG, on the other hand, is likely to display a modest growth over the report’s forecast period.

Ask An Expert @ https://www.tmrresearch.com/sample/sample?flag=ASK&rep_id=3077

Although the hepatitis E diagnostic tests market currently seems to be teeming with opportunities, the increasing prevalence of asymptomatic diseases, which are difficult to be detected, may pose severe growth challenges to this market. Furthermore, low level of awareness about therapeutics for Hepatitis E is also anticipated to hamper the growth of this market in the long run.

Global Hepatitis E Diagnostic Tests Market: Geographical Analysis

The global market for hepatitis E diagnostic tests is divided into the key regions of North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. On account of the high prevalence of hepatitis E in Asian countries such as India, Nepal, Pakistan, Bangladesh, Burma, Thailand, and Vietnam, Asia Pacific has emerged as the dominant regional segment for hepatitis E diagnostic tests and is predicted to continue to remain so in the years ahead too. This regional market is projected to hold more than 48% share in the overall market by the end of 2024.

Read Comprehensive Overview of Report@ https://www.tmrresearch.com/hepatitis-e-diagnostic-tests-market

Besides this, the Middle East and Africa are likely to emerge as a key market for hepatitis E diagnostic tests in the forthcoming years. Lack of safe drinking water and poor sanitation in countries such as Kenya, Nigeria, Morocco, and Uganda are reasons behind increasing prevalence of hepatitis E.

Global Hepatitis E Diagnostic Tests Market: Companies Mentioned

Some of the core companies in the hepatitis E diagnostic tests market are Beijing Wantai Biological Pharmacy, Mikrogen GmBH, Fast-track diagnostics Ltd., Hoffmann-La Roche Ltd., Altana Diagnostics GmbH, Primerdesign Ltd., MP Biomedicals LLC, Fortress Diagnostics Ltd., and Biokit S.A.

About Us

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hepatitis E Diagnostic Tests Market Rugged Expansion Foreseen by 2024 here

News-ID: 943112 • Views: 133

More Releases from TMR Research

Configuration Management Market 2018-2028 | CA Technologies, BMC Software, Oracl …
Global Configuration Management Market: Overview The demand within the global configuration management market is rising on account of advancements in the domain of product analysis and optimization. Development of a product or system is followed by a rigorous process of optimization to increase the efficiency and life of the system. The need to retain the utility and effectiveness of products has created tremendous demand within the global configuration management market. The
Security Orchestration Automation and Response Market | Qualitative Opportunitie …
Global Security Orchestration Automation and Response Market: Overview The demand within the global security orchestration automation and response is growing on account of advancements in the field of organizational security. The need to protect data and key assets across companies and organizations has played an integral role in the growth of the global security orchestration automation and response market. Furthermore, the growing level of automation across industrial and commercial units has
Global AI in Fashion Market Overview, Development, Segment by Type, Application …
AI in Fashion Market: Overview The global market for AI in fashion is expected to witness a stellar growth in coming few years. The market is expected flourish due to emergence of several fashion trends all across the globe. Fashion across the globe keeps on changing at a moment’s notice. It has become incredibly hard to keep a solid track of all the important fashion related activities. This has been a
Crowdsourced Security Market 2018 - 2028 | TMR Research
Crowdsourced Security Market: Overview The global crowdsourced security market is expected develop at a healthy pace in the coming years of the forecast period of 2018 to 2028. The mobile phone application segment of the crowdsourced security market is expected to develop at a rapid pace in these coming years. The rate of adoption of these mobile application is growing at a great pace and is thus helping the market to

All 5 Releases


More Releases for Hepatitis

Hepatitis E Therapeutics Pipeline Analysis 2018
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. Download the sample report at: https://www.pharmaproff.com/request-sample/1029 The World Health Organization (WHO) estimates released in 2018 stated that, every year, an estimated 20 million HEV infections worldwide, leading to
Hepatitis Drugs Market Opportunity Assessment Study
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in
Global Hepatitis A Vaccine Sales Market Report
In this report, the global Hepatitis A Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis A Vaccine for these regions, from 2013
Hepatitis B Vaccines Market Growth Analysis 2021
Hepatitis B refers to an infectious disease that is caused by hepatitis B virus. Symptoms of this disease are not visible in initial stages and develop after few weeks only. Hepatitis B virus is transmitted by exposure to infectious blood or body fluids of an infected person. This disease may even occur from the birth. Hepatitis B may be caused by blood transfusions, healthcare setting, sharing razors and dialysis. Hepatitis
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Global Hepatitis C Drug Sales Market 2017
In this report, the Global Hepatitis C Drug Market 2017 is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis C Drug for these regions, from 2012